Skip to main content
. 2020 Feb 3;9(3):e013695. doi: 10.1161/JAHA.119.013695

Figure 2.

Figure 2

Transplant‐free survival based on percentage predicted peak oxygen consumption (pVO 2) (A) and ventilatory efficiency (Ve/VCO 2 slope) (B). Comparison of survival curves for patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia undergoing cardiopulmonary exercise testing based on percentage predicted pVO 2 (<70% vs ≥70%) and Ve/VCO 2 slope (≤36 vs >36). HR indicates hazard ratio.